Report

The Philippines dialysis market is expected to grow at a CAGR of 4.20% during the forecast period of 2025-2034, driven by the increasing incidence of chronic kidney disease and improvements in healthcare infrastructure across the region.

Philippines Dialysis Market Overview

Dialysis is a medical treatment that replicates the kidney's function of filtering waste, excess fluids, and toxins from the blood when the kidneys are unable to perform these tasks effectively. There are two main types: haemodialysis, where a machine filters the blood through a dialyser, and peritoneal dialysis, which uses the lining of the abdomen to filter blood. Dialysis is crucial for individuals with chronic kidney disease or acute kidney failure. It helps maintain fluid balance, regulate electrolytes, and prevent waste accumulation, improving quality of life and extending survival in cases of kidney dysfunction.

Philippines Dialysis Market Growth Drivers

Exclusive Distribution Agreements Supporting Market Growth

The Philippine dialysis market is experiencing robust growth due to factors like the rising prevalence of chronic kidney disease (CKD) and the increasing demand for advanced dialysis treatments. For instance, in November �2024, Rockwell Medical, Inc., entered into a distribution agreement with Nephro Group, the largest dialysis provider in the Philippines. Under this deal, Rockwell will exclusively supply all dry hemodialysis concentrate products, including its CitraPure Acid and RenalPure Bicarbonate, to Nephro Group. This collaboration ensures a steady supply of high-quality dialysis products, improving treatment accessibility. This partnership is poised to enhance market growth in the Philippines, as it addresses growing demand while improving the quality of care available in dialysis clinics.

Strategic Acquisitions Driving Philippines Dialysis Market Value along with Increased Competition

The Philippines dialysis market continues to expand as healthcare providers look to meet the increasing demand for kidney care services. For instance, in March �2024, NephroPlus, a leading dialysis care provider, acquired Renal Therapy Solutions Inc. (RTSI), which operates six clinics in the Philippines. This acquisition positions NephroPlus as the third-largest dialysis network in the country. The acquisition is a critical step in NephroPlus's global expansion strategy, enhancing its service capacity and strengthening its presence in the Philippines. In the forecast period, this acquisition will drive market expansion by providing broader access to quality dialysis care, improving the overall treatment landscape, and enhancing market competitiveness.

Philippines Dialysis Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Rising Prevalence of Chronic Kidney Disease Driving Dialysis Demand

The prevalence of chronic kidney disease (CKD) in the Philippines is alarmingly high, with 35.94% of the adult population affected, much higher than the global rate of 9.1%-13.4%. This increase in CKD cases is directly contributing to a surge in the need for dialysis treatments, particularly hemodialysis, which remains the preferred option for 94% of patients. This growing demand for dialysis services is pushing healthcare providers to expand capacity and improve treatment accessibility. As the prevalence continues to rise, the Philippines dialysis market is poised for robust growth, with enhanced treatment options and greater availability expected in the forecast period.

Infrastructure Improvement Boosting Philippines Dialysis Market Value

In October 2023, the National Economic and Development Authority (NEDA) approved the Dialysis Centre Public-Private Partnership (PPP) project, marking a significant step in expanding dialysis infrastructure in the Philippines. The project focuses on upgrading the Renal Center Facility of the Baguio General Hospital and Medical Center (BGHMC), aiming to create a fully operational dialysis centre. This initiative is part of the government's broader plan to improve healthcare accessibility, providing affordable and advanced dialysis treatments to more patients. With increased government investment in healthcare infrastructure, the dialysis market is set to experience substantial growth, addressing the rising demand for renal care.

Strategic Collaborations Driving Early CKD Diagnosis and Awareness

A crucial trend in the Philippines dialysis market is the collaboration between public institutions and private companies to offer early CKD detection and cost-effective services. For instance, in December 2023, the Department of the Interior and Local Government (DILG) partnered with AstraZeneca to launch the ACT NOW programme, providing free Chronic Kidney Disease (CKD) testing across 12 provinces. This initiative aims to identify patients early, offering them better treatment alternatives and potentially reducing the need for more expensive dialysis treatments in the future. By fostering early diagnosis, this partnership is contributing to the long-term sustainability of the dialysis market in the Philippines.

Increasing Demand for Hemodialysis to Augment the Philippines Dialysis Market Growth

Hemodialysis remains the dominant treatment for end-stage renal disease in the Philippines, with 94% of affected patients opting for this method due to its cost-effectiveness. As the incidence of CKD continues to rise, driven by factors such as diabetes and hypertension, demand for hemodialysis services is expected to increase. Healthcare providers are focused on expanding hemodialysis centres and improving access to treatment. This trend is expected to significantly drive the growth of the dialysis market, as providers enhance capacity and increase outreach to underserved areas to meet the rising demand for dialysis services across the nation.

Philippines Dialysis Market Segmentation

Philippines Dialysis Market Report and Forecast 2025-2034" offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

- Hemodialysis �
??- Conventional Hemodialysis
??- Short Daily Hemodialysis
??- Nocturnal Hemodialysis

- Peritoneal Dialysis �

??- Continuous Ambulatory Peritoneal Dialysis
??- Automated Peritoneal Dialysis

Market Breakup by Product and Service

- Equipment �
??- Dialysis Machines
??- Water Treatment Systems
??- Others

- Consumables �
??- Dialyzers
??- Catheters
??- Others

- Dialysis Drugs
- Services

Market Breakup by End User

- In Center Dialysis
- Home Dialysis

Philippines Dialysis Market Share

Haemodialysis to Dominating the Market Segmentation by Type

Haemodialysis is expected to hold the largest market share in the market due to its widespread availability, high treatment efficacy, and increasing prevalence of chronic kidney disease (CKD). Conventional haemodialysis remains dominant, driven by its accessibility in both urban and rural areas. As per the analysis �by Expert Market Research, the global haemodialysis and peritoneal dialysis market is expected to grow at a CAGR of 5.5% during the forecast period of 2025-2034.

The demand for nocturnal and short-daily haemodialysis is also growing as patients seek flexibility and improved quality of life. Future growth is fuelled by expanding healthcare infrastructure and government initiatives to improve CKD treatment access. Haemodialysis will continue to lead, supported by technological advancements in dialysis machines and increasing awareness of treatment options.

Philippines Dialysis Market Segmentation by Product and Service to Witness Significant Growth

Consumables, including dialyzers and catheters, will likely dominate the market due to their recurring demand and crucial role in dialysis procedures. Rising CKD cases and the need for continuous replacement of consumables drive this segment. Additionally, the increasing adoption of single-use consumables to reduce infection risks further boosts market value. Future growth is bolstered by innovations in biocompatible materials and the growing shift towards personalised dialysis solutions. As these consumables are integral to the treatment process, their demand is expected to remain strong, ensuring they continue leading the market during the forecast period.

Market Share by End User to Undergo Growth in the Forecast Period

Based on end users, in-centre dialysis is predicted to dominate the market as it offers patients access to specialised care and skilled healthcare professionals. The centralisation of services enables cost-effectiveness and better management of resources, making it the preferred option for many patients. The growth of dialysis clinics in urban and semi-urban regions contributes to the segment's expansion. Future growth is anticipated due to increasing investments in dialysis centres and enhanced patient support services. While home dialysis is gaining traction, in-centre dialysis will maintain its leadership due to its reliability, established infrastructure, and better accessibility.

Philippines Dialysis Market Analysis by Region

The Manila and National Capital Region (NCR) holds the largest market share in the Philippines dialysis sector due to significant healthcare infrastructure improvements and a rising demand for dialysis services. For instance, in June �2023, the Philippine Health Insurance Corporation (PhilHealth) expanded hemodialysis coverage from 90 to 156 sessions, allowing patients to receive three sessions per week for an affordable cost of approximately P2,600 per session. This has increased access to dialysis for patients across the region. Additionally, Manila has become a hub for medical tourism, attracting foreign investments due to its affordable yet high-quality healthcare services. These factors combine to create a robust growth environment for the dialysis market in this region.

Leading Players in the Philippines Dialysis Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Fresenius SE & Co. KGaA

Headquartered in Bad Homburg, Germany, Fresenius SE & Co. KGaA was established in 1912. A global healthcare group, it operates across the areas of dialysis, hospital care, and medical devices. Its dialysis division, Fresenius Medical Care, is a market leader, in providing renal care services and dialysis equipment. The company also offers hospital infrastructure, injectable medicines, and surgical devices. Fresenius focuses on improving patient outcomes through innovative technologies, expanding its footprint in global healthcare markets.

B Braun SE

Founded in 1839 and headquartered in Melsungen, Germany, B Braun SE is a leading medical and pharmaceutical device manufacturer. Its portfolio includes products for infusion therapy, pain management, surgical instruments, and dialysis treatments. The company provides solutions for renal care, particularly through its B. Braun Avitum division, which offers dialysis machines and related services. B Braun has a strong global presence and continues to innovate in medical technology, enhancing healthcare delivery worldwide.

Baxter

Baxter, established in 1931 and headquartered in Deerfield, Illinois, USA, is a global healthcare company focused on medical products and services. Its portfolio spans across renal care, parenteral nutrition, and intravenous therapies. Notably, Baxter's dialysis division offers haemodialysis products and peritoneal dialysis solutions. With a commitment to advancing clinical care, Baxter provides life-saving therapies and medical devices, focusing on innovation and improving patient outcomes in both hospital and home settings.

BD (Becton, Dickinson and Company)

Founded in 1897 and headquartered in Franklin Lakes, New Jersey, USA, BD is a global medical technology company. It offers a broad range of products, including diagnostic systems, medical devices, and laboratory instruments. BD is a prominent player in the dialysis market, supplying devices such as catheters, needles, and infusion pumps for renal care. The company's innovations focus on improving patient safety and outcomes in dialysis treatments, alongside its extensive presence in diagnostics, biosciences, and healthcare-related technologies.

Other key players in the market include Nikkiso Co., Ltd., Nipro, Hemotek, Nephro Group Dialysis Center, and Clearbridge Medical Philippines Dialysis Center.

Key Questions Answered in the Philippines Dialysis Market

- What was the Philippines dialysis market value in 2024?
- What is the Philippines dialysis market forecast outlook for 2025-2034?
- How is the market segmented based on type?
- How is the market segmented based on products and services?
- How is the market segmented based on end users?
- What are the major factors aiding the Philippines dialysis market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Philippines dialysis market trends?
- Which type will lead the market segment?
- Which product and services will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the Philippines dialysis market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?